Medical Marijuana, Inc. Subsidiary Kannaway Launches New Hemp + Calm CBD Oral Applicator in Europe
M
edical Marijuana, Inc. (OTC: MJNA) (the Company), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced that its subsidiary Kannaway has launched a new cannabidiol (CBD) product, its Hemp + Calm Oral Applicator, in Europe.
This product is the Company's first product available in Europe that is made using its Blue Label Real Scientific Hemp Oil (RSHO).
Europe has proven to be our largest market since we launched across the continent in 2018, said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. As the European CBD market continues to grow exponentially, we intend to continue innovating and launching new products that fit the needs of European consumers.
Each Kannaway Hemp + Calm Oral Applicator contains 2,000 mg of CBD from broad-spectrum hemp oil. The CBD used in the product is derived from non-GMO hemp, scientifically extracted using a solvent-free CO2 process, and quality-certified through the Company's Triple Lab Testing process to deliver the potential natural benefits of hemp CBD.
According to the Brightfield Group, the CBD market in Europe is expected to grow over 400 percent by 2023. Kannaway is the first direct selling company to legally offer hemp-based CBD wellness products to the entire European market.
Information on Kannaway in Europe or on how to become a European Kannaway Brand Ambassador can be found at https//kannaway.com/.
✔️ Medical Marijuana, Inc. Subsidiary Kannaway Launches New Hemp + Calm CBD Oral Applicator in Europe
💕 Found this article helpful? Spread the word and support us!